{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:48:22Z","timestamp":1754146102742,"version":"3.41.2"},"reference-count":30,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Alcohol withdrawal syndrome (AWS) is a complication of alcohol use disorder commonly encountered across various healthcare settings. Management of AWS is routinely conducted in the inpatient setting; however, in numerous patients, ambulatory alcohol withdrawal management (AAWM) is safe, effective, and recommended. There is no published evidence describing psychiatric pharmacists, otherwise known as Psychiatric Clinical Pharmacist Practitioners (psychiatric-CPP) impact on AAWM.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a single-centered, retrospective review conducted at a Veterans Affairs Healthcare System that aimed to quantify and describe the clinical impact of psychiatric-CPP\u2013led AAWM. Veterans who participated in AAWM with a psychiatric-CPP from April 1, 2019, to December 31, 2023, were included in the study. Descriptive statistics were used.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The rate of successful AAWM was 67.6% (n = 23) for 34 total withdrawal episodes. The most common reason for failure was breakthrough withdrawal or cravings at 45.5% (n = 5). The most common medications utilized included gabapentin (62.9%; n = 22), chlordiazepoxide (8.6%; n = 3), and diazepam (8.6%; n = 3). In 3 AAWM episodes, no medications were used. Cost avoidance of outpatient management rather than inpatient management was calculated to be $139,361.24. There were 2 alcohol-related emergency department visits within the first month of psychiatric-CPP\u2013conducted AAWM, and no serious medical complications were noted.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Psychiatric-CPPs practicing in a Veterans Affairs Healthcare System successfully completed AAWM in a majority of the episodes that were attempted. Additionally, few patients were seen in an emergency department setting for alcohol-related matters after initiation of AAWM, perhaps emphasizing the safety of this service and the need for further use.<\/jats:p>\n<\/jats:sec>","DOI":"10.9740\/mhc.2025.06.170","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:35:09Z","timestamp":1748838909000},"page":"170-5","source":"Crossref","is-referenced-by-count":0,"title":["Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management"],"prefix":"10.9740","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2476-7779","authenticated-orcid":true,"given":"Maxwell","family":"Lamb","sequence":"first","affiliation":[{"name":"(Corresponding author) Mental Health Clinical Pharmacy Specialist, Carl Vinson Veterans Affairs Medical Center, Dublin, Georgia, maxwell.lamb@va.gov"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-5013","authenticated-orcid":true,"given":"Michelle","family":"Colvard","sequence":"additional","affiliation":[{"name":"Substance Use Disorder Clinical Pharmacist Practitioner, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6493-7420","authenticated-orcid":true,"given":"Jonathan","family":"Lister","sequence":"additional","affiliation":[{"name":"Mental Health Clinical Pharmacist Practitioner, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2833-444X","authenticated-orcid":true,"given":"Eric","family":"Johnson","sequence":"additional","affiliation":[{"name":"Mental Health Clinical Pharmacist Practitioner, Veterans Affairs Tennessee Valley Healthcare System, Murfreesboro, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"issue":"8","key":"i2168-9709-15-3-170-b01","series-title":"JAMA Psychiatry","first-page":"757","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","unstructured":"Grant BF,Goldstein RB,Saha TD,Chou SP,Jung J,Zhang H, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015;72(8):757-66. DOI: 10.1001\/jamapsychiatry.2015.0584"},{"issue":"3","key":"i2168-9709-15-3-170-b02","series-title":"Am Fam Physician","first-page":"253","article-title":"Alcohol withdrawal syndrome: outpatient management","volume":"104","author":"Tiglao","year":"2021","unstructured":"Tiglao SM,Meisenheimer ES,Oh RC. Alcohol withdrawal syndrome: outpatient management. Am Fam Physician. 2021;104(3):253-62. PMID: 34523874"},{"key":"i2168-9709-15-3-170-b03","series-title":"Subst Abuse Rehabil","first-page":"69","article-title":"Substance use disorders in military veterans: prevalence and treatment challenges","volume":"8","author":"Teeters","year":"2017","unstructured":"Teeters JB,Lancaster CL,Brown DG,Back SE. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017;8:69-77. DOI: 10.2147\/SAR.S116720"},{"issue":"4","key":"i2168-9709-15-3-170-b04","series-title":"Am J Drug Alcohol Abuse","first-page":"549","article-title":"Ambulatory medical detoxification for alcohol","volume":"21","author":"Abbott","year":"1995","unstructured":"Abbott PJ,Quinn D,Knox L. Ambulatory medical detoxification for alcohol. Am J Drug Alcohol Abuse. 1995;21(4):549-63. DOI: 10.3109\/00952999509002715"},{"issue":"6","key":"i2168-9709-15-3-170-b05","series-title":"N Engl J Med","first-page":"358","article-title":"Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome","volume":"320","author":"Hayashida","year":"1989","unstructured":"Hayashida M,Alterman AI,McLellan AT,O\u2019Brien CP,Purtill JJ,Volpicelli JR, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med. 1989;320(6):358-65. DOI: 10.1056\/NEJM198902093200605"},{"issue":"2","key":"i2168-9709-15-3-170-b06","series-title":"Psychiatr Serv","first-page":"200","article-title":"Outcomes of patients in a VA ambulatory detoxification program","volume":"48","author":"Wiseman","year":"1997","unstructured":"Wiseman EJ,Henderson KL,Briggs MJ. Outcomes of patients in a VA ambulatory detoxification program. Psychiatr Serv. 1997;48(2):200-3. DOI: 10.1176\/ps.48.2.2"},{"issue":"4","key":"i2168-9709-15-3-170-b07","series-title":"Am J Psychiatry","first-page":"407","article-title":"Outpatient alcohol detoxification: initial findings on 564 patients","volume":"132","author":"Feldman","year":"1975","unstructured":"Feldman DJ,Pattison EM,Sobell LC,Graham T,Sobell MB. Outpatient alcohol detoxification: initial findings on 564 patients. Am J Psychiatry. 1975;132(4):407-12. DOI: 10.1176\/ajp.132.4.407"},{"issue":"6","key":"i2168-9709-15-3-170-b08","series-title":"Int J Addict","first-page":"1031","article-title":"Outpatient detoxification of the alcoholic","volume":"17","author":"Stinnett","year":"1982","unstructured":"Stinnett JL. Outpatient detoxification of the alcoholic. Int J Addict. 1982;17(6):1031-46. DOI: 10.3109\/10826088209057773"},{"issue":"8","key":"i2168-9709-15-3-170-b09","series-title":"Br J Addict","first-page":"929","article-title":"The outcome of outpatient withdrawal from alcohol","volume":"83","author":"Webb","year":"1988","unstructured":"Webb M,Unwin A. The outcome of outpatient withdrawal from alcohol. Br J Addict. 1988;83(8):929-34. DOI: 10.1111\/j.1360-0443.1988.tb01585.x"},{"key":"i2168-9709-15-3-170-b10","series-title":"Br J Psychiatry","first-page":"871","article-title":"A structured programme for out-patient alcohol detoxification","volume":"156","author":"Collins","year":"1990","unstructured":"Collins MN,Burns T,van den Berk PA,Tubman GF. A structured programme for out-patient alcohol detoxification. Br J Psychiatry. 1990;156:871-4. DOI: 10.1192\/bjp.156.6.871"},{"issue":"4","key":"i2168-9709-15-3-170-b11","series-title":"Eur Addict Res","first-page":"180","article-title":"Outpatient alcohol detoxification: implementation efficacy and outcome effectiveness of a model project","volume":"10","author":"Soyka","year":"2004","unstructured":"Soyka M,Horak M. Outpatient alcohol detoxification: implementation efficacy and outcome effectiveness of a model project. Eur Addict Res. 2004;10(4):180-7. DOI: 10.1159\/000079840"},{"issue":"6","key":"i2168-9709-15-3-170-b12","series-title":"J Clin Psychiatry","first-page":"289","article-title":"Individualized treatment for outpatients withdrawing from alcohol","volume":"59","author":"Wiseman","year":"1998","unstructured":"Wiseman EJ,Henderson KL,Briggs MJ. Individualized treatment for outpatients withdrawing from alcohol. J Clin Psychiatry. 1998;59(6):289-93. DOI: 10.4088\/jcp.v59n0603"},{"issue":"12","key":"i2168-9709-15-3-170-b13","series-title":"Addiction","first-page":"1773","article-title":"The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects","volume":"91","author":"Finney","year":"1996","unstructured":"Finney JW,Hahn AC,Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction. 1996;91(12):1773-96; discussion 1803-20. DOI: 10.1046\/j.1360-0443.1996.911217733.x"},{"key":"i2168-9709-15-3-170-b14","article-title":"The American Society of Addiction Medicine Clinical Practice Guideline on Alcohol Withdrawal Management [Internet]","author":"The American Society of Addiction Medicine","year":"2020","unstructured":"The American Society of Addiction Medicine. The American Society of Addiction Medicine Clinical Practice Guideline on Alcohol Withdrawal Management [Internet]. Rockville, MD; 2020 [cited 2024 Apr 1]. Available from: https:\/\/www.asam.org\/docs\/default-source\/quality-science\/the_asam_clinical_practice_guideline_on_alcohol-1.pdf"},{"issue":"2","key":"i2168-9709-15-3-170-b15","series-title":"Proc (Bayl Univ Med Cent)","first-page":"169","article-title":"The alcohol detoxification protocol and creation of the e-consult at Central Texas Veterans health care system","volume":"33","author":"Hall","year":"2020","unstructured":"Hall JA,Coppin JD,Ghauri A,Martinez G. The alcohol detoxification protocol and creation of the e-consult at Central Texas Veterans health care system. Proc (Bayl Univ Med Cent). 2020;33(2):169-71. DOI: 10.1080\/08998280.2020.1727707"},{"issue":"4","key":"i2168-9709-15-3-170-b16","series-title":"J Gen Intern Med","first-page":"587","article-title":"Who needs inpatient detox? Development and implementation of a hospitalist protocol for the evaluation of patients for alcohol detoxification","volume":"29","author":"Stephens","year":"2014","unstructured":"Stephens JR,Liles EA,Dancel R,Gilchrist M,Kirsch J,DeWalt DA. Who needs inpatient detox? Development and implementation of a hospitalist protocol for the evaluation of patients for alcohol detoxification. J Gen Intern Med. 2014;29(4):587-93. DOI: 10.1007\/s11606-013-2751-3"},{"issue":"9","key":"i2168-9709-15-3-170-b17","series-title":"Alcohol Clin Exp Res","first-page":"1582","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal","volume":"33","author":"Myrick","year":"2009","unstructured":"Myrick H,Malcolm R,Randall PK,Boyle E,Anton RF,Becker HC, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33(9):1582-8. DOI: 10.1111\/j.1530-0277.2009.00986.x"},{"issue":"7-8","key":"i2168-9709-15-3-170-b18","series-title":"Ann Pharmacother","first-page":"961","article-title":"Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment","volume":"47","author":"Stock","year":"2013","unstructured":"Stock CJ,Carpenter L,Ying J,Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother. 2013;47(7-8):961-9. DOI: 10.1345\/aph.1R751"},{"issue":"17","key":"i2168-9709-15-3-170-b19","series-title":"Am J Health Syst Pharm","first-page":"1559","article-title":"Proposed guidance on cost-avoidance studies in pharmacy practice","volume":"78","author":"Patanwala","year":"2021","unstructured":"Patanwala AE,Narayan SW,Haas CE,Abraham I,Sanders A,Erstad BL. Proposed guidance on cost-avoidance studies in pharmacy practice. Am J Health Syst Pharm. 2021;78(17):1559-67. DOI: 10.1093\/ajhp\/zxab211"},{"key":"i2168-9709-15-3-170-b20","series-title":"Improving access to high-quality mental health care for veterans: proceedings of a workshop","author":"Meisnere","year":"2023","unstructured":"Meisnere M,Formentos A,Snair M. Improving access to high-quality mental health care for veterans: proceedings of a workshop. The National Academies Press; 2023."},{"issue":"3","key":"i2168-9709-15-3-170-b21","series-title":"Alcohol Alcohol","first-page":"318","article-title":"Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting","volume":"46","author":"Elholm","year":"2011","unstructured":"Elholm B,Larsen K,Hornnes N,Zierau F,Becker U. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol. 2011;46(3):318-23. DOI: 10.1093\/alcalc\/agr020"},{"issue":"5","key":"i2168-9709-15-3-170-b22","series-title":"Pharmacopsychiatry","first-page":"184","article-title":"Efficacy and safety of levetiracetam for outpatient alcohol detoxification","volume":"43","author":"M\u00fcller","year":"2010","unstructured":"M\u00fcller CA,Sch\u00e4fer M,Schneider S,Heimann HM,Hinzpeter A,Volkmar K, et al. Efficacy and safety of levetiracetam for outpatient alcohol detoxification. Pharmacopsychiatry. 2010;43(5):184-9. DOI: 10.1055\/s-0030-1249098"},{"key":"i2168-9709-15-3-170-b23","series-title":"J Psychiatr Res","first-page":"1","article-title":"Predicting relapse after alcohol use disorder treatment in a high-risk cohort: the roles of anhedonia and smoking","volume":"126","author":"Nguyen","year":"2020","unstructured":"Nguyen LC,Durazzo TC,Dwyer CL,Rauch AA,Humphreys K,Williams LM, et al. Predicting relapse after alcohol use disorder treatment in a high-risk cohort: the roles of anhedonia and smoking. J Psychiatr Res. 2020;126:1-7. DOI: 10.1016\/j.jpsychires.2020.04.003"},{"issue":"5","key":"i2168-9709-15-3-170-b24","series-title":"JAMA Intern Med","first-page":"728","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial","volume":"180","author":"Anton","year":"2020","unstructured":"Anton RF,Latham P,Voronin K,Book S,Hoffman M,Prisciandaro J, et al. Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial. JAMA Intern Med. 2020;180(5):728-36. DOI: 10.1001\/jamainternmed.2020.0249"},{"issue":"1","key":"i2168-9709-15-3-170-b25","series-title":"JAMA Intern Med","first-page":"70","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","unstructured":"Mason BJ,Quello S,Goodell V,Shadan F,Kyle M,Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(1):70-7. DOI: 10.1001\/jamainternmed.2013.11950"},{"key":"i2168-9709-15-3-170-b26","article-title":"Drug Enforcement Administration. Midlevel practitioner authorization by state [Internet]","author":"Diversion Control Division.","year":"2022","unstructured":"Diversion Control Division. Drug Enforcement Administration. Midlevel practitioner authorization by state [Internet]. Washington, DC: US Department of Justice; 2022 [cited 2024 Sep 19]. Available from: https:\/\/www.deadiversion.usdoj.gov\/drugreg\/practioners\/mlp_by_state.pdf"},{"key":"i2168-9709-15-3-170-b27","unstructured":"Nevada Statue Chapter 290, SB 229, Section 2. 2021 Statutes of Nevada, Pages 1587-1754 (June 2021)."},{"key":"i2168-9709-15-3-170-b28","unstructured":"House Bill 4002, Section 7. 82nd Oregon Legislative Assembly (April 2024)."},{"key":"i2168-9709-15-3-170-b29","unstructured":"HB24-1045. Treatment for Substance Use Disorders. 74th Colorado General Assembly (June 2024)."},{"key":"i2168-9709-15-3-170-b30","unstructured":"House File 555. 90th Iowa General Assembly (April 2024)."}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/15\/3\/article-p170.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/15\/3\/article-p170.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/15\/3\/article-p170.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:30Z","timestamp":1752796830000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/15\/3\/article-p170.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2025.06.170","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}